…As Akwa Ibom PSN Presents Award of Commendation
Prominent figures in Nigeria’s pharmaceutical industry, including Prof. Cyril Usifoh, immediate past president of the Pharmaceutical Society of Nigeria (PSN), Mazi Sam Ohuabunwa, former PSN president, and others have praised Geneith Pharmaceuticals’ unveiling of seven new products at the 97th Annual PSN Conference in Uyo, Akwa Ibom State.
Applauding Geneith’s commitment to advancing healthcare, the eminent pharmacists highlighted the company’s innovative contributions towards improving health outcomes across Nigeria, saying the company has further enhanced the health of the people through the production of quality pharmaceuticals.
Geneith’s newly launched products, which include Sitanom-50/1000, Larykul-Plus, Boneflex Forte, Celoxigen-200, Klinfast Forte, Vildamet-50/1000, and Ceflonac ER 200, were designed to meet a range of therapeutic needs, underscoring Geneith’s dedication to addressing Nigeria’s healthcare challenges.
In his remarks during the unveiling, Prof. Cyril Usifoh commended Geneith Pharmaceuticals for its commitment to quality and innovation. “Geneith has consistently shown a strong dedication to addressing Nigeria’s healthcare needs through high-quality pharmaceutical products,” Usifoh stated. “The launch of these seven new products is a testament to their focus on improving lives and setting higher standards in our industry. This is the kind of progress we need to see more of—initiatives that directly enhance the health and well-being of Nigerians.”
Also speaking, Ohuabunwa, a former Chairman and CEO of Pfizer Nigeria and Neimeth Pharmaceuticals, commended Geneith Pharmaceuticals for its steadfast commitment to quality and innovation in healthcare. “When I was invited to the unveiling of these seven new products, I quickly identified with Geneith because the integrity of this company precedes its products,” he stated.
Ohuabunwa recalled Geneith’s early innovations, such as one of the first Malaria Test Kit in the market, and products like Camosunate, which has gained strong market presence. “Geneith has demonstrated a clear, progressive trajectory, from food importation to franchise and contract manufacturing, and now towards local production,” he noted.
Offering advice to other companies, Ohuabunwa emphasised the importance of reputation in pharmaceuticals: “A pharmaceutical product is taken with trust; quality, efficacy, and safety cannot be compromised. If you cut corners, your brand will eventually suffer as people evaluation is to the effectiveness of what they use. My advice to others is to ensure quality without compromise like Geneith, as consistent quality pays off in the long run.”
Speaking in the same vein, the duo of Pharm. Nsikak Edet Effiong and Pharm. Bede Aguocha Anyanwu underscored the reliability and impact of Geneith Pharmaceuticals’ products on healthcare delivery in Nigeria, saying Geneith is a company known for quality and consistency.
According to Pharm. Anyanwu, who is a deputy director of Pharmaceutical Services, and head, paediatric outpatient/emergency pharmacy at the UUTH, “The effectiveness of medication lies in achieving the desired results, and Geneith’s products deliver on that promise. We see positive outcomes in our patients, and that’s a testament to the value Geneith brings to healthcare.”
Pharm. Effiong, LOC Chairman for the Ibom 2024 PSN Conference and deputy director of pharmaceutical services, UUTH, also highlighted his longstanding partnership with Geneith, recognising the company’s focus on cost-effectiveness, quality, and efficacy. “Geneith’s products align with Nigeria’s drug policy by meeting the essential criteria of quality, affordability, and availability and that was the reason the Akwa Ibom State PSN decided to give them award of best Innovative Pharmaceutical Company” Effiong stated.
In her reaction, Pharm. Judith Udeh, principal manager (marketing) and head of Hospital and Institutional Business for Geneith Pharmaceuticals, expressed her pride in the company’s commitment to quality and innovation, saying Geneith is known for developing innovative products that stand out in the market.
“In 2024, we introduced seven new products, each unique and impactful, many of which set a standard that others follow. The validation we received from industry leaders, including PSN executives, speaks volumes about our dedication to quality, efficacy, and affordability.”
Echoing Udeh’s sentiments, Pharm. Abimbola Bowoto, assistant general manager of Sales and Marketing at Geneith Pharmaceuticals, highlighted the strategic vision behind unveiling the products at the PSN Conference. “Our goal was to showcase Geneith’s distinctiveness in the pharmaceutical industry by offering products that are unparalleled in quality, affordability, and availability,” Bowoto explained.
Bowoto added that Geneith’s dedication to balancing quality, affordability, and availability sets it apart, giving Nigerians greater access to essential medicines while reinforcing the company’s reputation as a leader in the industry.
It would be recalled that the Geneith launched Coatal Forte Soft Gelatin Capsules—a formulation of artemether and lumefantrine, few months ago.
